← Moderna, Inc. MRNA
Market Price
$63.28
Market Cap
$25.26B
P/E Ratio
N/A
Revenue (FY 2025)
↓-26.1% YoY
$314.00M
3-Yr CAGR: 16.2%
Net Income
N/A
Net Margin: N/A
Free Cash Flow
↑36.9% YoY
-$1.96B
FCF Yield: -7.74%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
N/A
ROA: N/A
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (MRNA)
All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
- FY 2018: Revenue YoY (+77.4%) is identical to Gross Profit YoY (+77.4%). Verify the underlying Revenue and Gross Profit values for FY 2018 and FY 2017.
- FY 2019: Revenue YoY (+42.6%) is identical to Gross Profit YoY (+42.6%). Verify the underlying Revenue and Gross Profit values for FY 2019 and FY 2018.
- FY 2022: Revenue YoY (+1011.1%) is identical to Gross Profit YoY (+1011.1%). Verify the underlying Revenue and Gross Profit values for FY 2022 and FY 2021.
- FY 2023: Revenue YoY (+110.5%) is identical to Gross Profit YoY (+110.5%). Verify the underlying Revenue and Gross Profit values for FY 2023 and FY 2022.
- FY 2024: Revenue YoY (+1.0%) is identical to Gross Profit YoY (+1.0%). Verify the underlying Revenue and Gross Profit values for FY 2024 and FY 2023.
- FY 2025: Revenue YoY (-26.1%) is identical to Gross Profit YoY (-26.1%). Verify the underlying Revenue and Gross Profit values for FY 2025 and FY 2024.
| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2017 | $15.2M | — | $15.2M | — | — | — | — | $-331.5M | $-351.4M | — |
| FY 2018 | $27.0M | +77.4% | $27.0M | — | — | — | — | $-330.9M | $-343.8M | +2.2% |
| FY 2019 | $38.5M | +42.6% | $38.5M | — | — | — | — | $-459.0M | $-463.6M | -34.9% |
| FY 2020 | $24.7M | -35.9% | $16.8M | — | — | — | — | $2,027.0M | $2,009.4M | +533.4% |
| FY 2021 | $18.0M | -27.2% | $18.0M | — | — | — | — | $13,620.0M | $13,509.0M | +572.3% |
| FY 2022 | $200.0M | +1,011.1% | $200.0M | — | — | — | — | $4,981.0M | $4,909.0M | -63.7% |
| FY 2023 | $421.0M | +110.5% | $421.0M | — | — | — | — | $-3,118.0M | $-3,248.0M | -166.2% |
| FY 2024 | $425.0M | +1.0% | $425.0M | — | — | — | — | $-3,004.0M | $-3,101.0M | +4.5% |
| FY 2025 | $314.0M | -26.1% | $314.0M | — | — | — | — | $-1,873.0M | $-1,956.0M | +36.9% |
Valuation
Market Price
$63.28
Market Cap
$25.26B
Enterprise Value
$23.25B
P/E Ratio
N/A
P/B Ratio
2.90
FCF Yield
-7.74%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
26.57%
Operating Margin
N/A
Net Margin
N/A
Return on Equity (ROE)
N/A
Return on Assets (ROA)
N/A
Asset Turnover
0.03x
Revenue 3-Yr CAGR
16.23%
Financial Health & Liquidity
Current Ratio
2.21
Cash Ratio
14.03
Debt / Equity
0.068
Debt / Assets
0.048
Cash & Equivalents
$2.60B
Total Debt
$590.00M
Book Value / Share
$21.80
Cash Flow Efficiency
Operating Cash Flow
-$1.87B
Capital Expenditures (CapEx)
$83.00M
Free Cash Flow
-$1.96B
OCF / Revenue
-596.50%
FCF / Revenue
-622.93%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$21.80
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$12.34B
Total Liabilities
$12.34B
Stockholders' Equity
$8.65B
Current Assets
$408.00M
Current Liabilities
$185.00M